Dr. Dmitriy M. Niyazov, MD

Dr. Niyazov practices at Duke Health Integrated Practice, Inc. in Durham, North Carolina.

Dr. Niyazov's NPI, 1699950899, was assigned on January 7, 2008. Dr. Niyazov graduated from University of Rochester Medical Center in 2001. Dr. Niyazov holds Louisiana license MD.201813.

Dr. Niyazov's primary practice is Duke Health Integrated Practice, Inc., at 2351 Erwin Rd, Durham, NC 27705 in Durham County. The practice phone is (919) 620-4855.

Dr. Niyazov's primary practice is Duke Health Integrated Practice, Inc. in Durham, North Carolina. Dr. Niyazov is also affiliated with Duke University Hospital. The medical group on file is Duke Health Integrated Practice. Dmand AI also links Dr. Niyazov to 2 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Niyazov practices, 2 sites in all. Vendor and product names are available with a free account.

Clinical genetics (m.d.) is Dr. Niyazov's primary specialty in the NPI Registry, under taxonomy code 207SG0201X. Dr. Niyazov is board certified in clinical genetics and genomics by the American Board of Medical Genetics and Genomics. Dmand AI has Dr. Niyazov's licenses on file in 2 states: Louisiana and North Carolina.

CMS data shows 13 Medicare services from Dr. Niyazov across 1 procedure code in 2024, all of them office visits, for 19 Medicare patients. Medicare paid $2,034 for them. Every service was in an office.

CMS counts 19 Medicare patients who saw Dr. Niyazov in 2024. The largest group is 85 and over, with 0 patients. 58% of them have high blood pressure. Their average risk score is 2.72, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Niyazov's median patient age at 27, with 62% women.

In 2023, Dr. Niyazov wrote 16 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $889,574 in total drug cost. In 2022, CMS named 51 claims across 3 drugs.

Dr. Niyazov accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Niyazov as offering telehealth.

Dmand AI links 56 papers to Dr. Niyazov, published from 2011 to 2024. 2019 was the busiest year, with 6. The most frequent topics are Intellectual Disability, Phenotype and Magnetic Resonance Imaging. Dr. Niyazov has published most often in Am J Med Genet A. Dr. Niyazov's most frequent co-authors are Wendy Chung, MD, Christian Patrick Schaaf, MD and Rhonda E. Schnur, MD.

CMS Open Payments shows 528 general payments to Dr. Niyazov from 13 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 78% of the total. Sanofi and Genzyme US Companies paid the most, $218,467.

Dmand AI lists 7 awards for Dr. Niyazov, most recently Best Doctors of Lousiana in 2016.

Dr. Niyazov graduated from University of Rochester Medical Center in 2001. Dr. Niyazov is a member of American College of Medical Genetics and Genomics, American Society of Human Genetics and Mitochondrial Medicine Society.

Dr. Niyazov is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.